Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,109 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Key patient demographics shape innate immune topography in noncritical hypoxic COVID-19 pneumonia.
Billi AC, Wasikowski R, Ma F, Yalavarthi S, Hoy CK, Zuo Y, Patrick MT, Shah N, Parker C, Aaronson C, Harbaugh A, Lucido MF, Shedden K, Rao K, IglayReger HB, Burant CF, Kahlenberg JM, Tsoi LC, Gudjonsson JE, Knight JS, Kanthi Y. Billi AC, et al. Among authors: zuo y. JCI Insight. 2023 Aug 22;8(16):e166110. doi: 10.1172/jci.insight.166110. JCI Insight. 2023. PMID: 37606044 Free PMC article.
Autoantibodies stabilize neutrophil extracellular traps in COVID-19.
Zuo Y, Yalavarthi S, Navaz S, Hoy C, Harbaugh A, Gockman K, Zuo M, Madison JA, Shi H, Kanthi Y, Knight JS. Zuo Y, et al. Among authors: zuo m. medRxiv [Preprint]. 2021 Jun 24:2021.03.31.21254692. doi: 10.1101/2021.03.31.21254692. medRxiv. 2021. PMID: 33851189 Free PMC article. Updated. Preprint.
Anti-Neutrophil Extracellular Trap Antibodies in Antiphospholipid Antibody-Positive Patients: Results From the Antiphospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking Clinical Database and Repository.
Zuo Y, Navaz S, Tsodikov A, Kmetova K, Kluge L, Ambati A, Hoy CK, Yalavarthi S, de Andrade D, Tektonidou MG, Sciascia S, Pengo V, Ruiz-Irastorza G, Belmont HM, Gerosa M, Fortin PR, de Jesus GR, Branch DW, Andreoli L, Rodriguez-Almaraz E, Petri M, Cervera R, Willis R, Karp DR, Li QZ, Cohen H, Bertolaccini ML, Erkan D, Knight JS; Antiphospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking. Zuo Y, et al. Arthritis Rheumatol. 2023 Aug;75(8):1407-1414. doi: 10.1002/art.42489. Epub 2023 May 18. Arthritis Rheumatol. 2023. PMID: 36862141 Free article.
Non-criteria antiphospholipid antibodies and calprotectin as potential biomarkers in pediatric antiphospholipid syndrome.
Sloan EE, Kmetova K, NaveenKumar SK, Kluge L, Chong E, Hoy CK, Yalavarthi S, Sarosh C, Baisch J, Walters L, Nassi L, Fuller J, Turnier JL, Pascual V, Wright TB, Madison JA, Knight JS, Zia A, Zuo Y. Sloan EE, et al. Among authors: zuo y. Clin Immunol. 2024 Apr;261:109926. doi: 10.1016/j.clim.2024.109926. Epub 2024 Feb 13. Clin Immunol. 2024. PMID: 38355030
Longitudinal plasma proteomics in CAR T-cell therapy patients implicates neutrophils and NETosis in the genesis of CRS.
Flora C, Olesnavich M, Zuo Y, Sandford E, Madhukar R, Rozwadowski M, Sugur K, Ly A, Canbaz AA, Shedeck A, Li G, Geer MJ, Yanik GA, Ghosh M, Frame DG, Bonifant CL, Jain T, Knight JS, Choi SW, Tewari M. Flora C, et al. Among authors: zuo y. Blood Adv. 2024 Mar 26;8(6):1422-1426. doi: 10.1182/bloodadvances.2023010728. Blood Adv. 2024. PMID: 38266157 Free PMC article. No abstract available.
Damage measured by Damage Index for Antiphospholipid Syndrome (DIAPS) in antiphospholipid antibody-positive patients included in the APS ACTION registry.
Balbi GGM, Ahmadzadeh Y, Tektonidou MG, Pengo V, Sciascia S, Ugarte A, Belmont HM, Lopez-Pedrera C, Fortin PR, Wahl D, Gerosa M, de Jesús GR, Ji L, Atsumi T, Efthymiou M, Branch DW, Nalli C, Rodriguez Almaraz E, Petri M, Cervera R, Knight JS, Artim-Esen B, Willis R, Bertolaccini ML, Cohen H, Roubey R, Erkan D, de Andrade DCO; for AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository (APS ACTION). Balbi GGM, et al. Rheumatology (Oxford). 2024 Mar 1;63(3):772-779. doi: 10.1093/rheumatology/kead292. Rheumatology (Oxford). 2024. PMID: 37307082
3,109 results